Luca C.
- Country
- Italy
- Department
- Ocular Immunology Unit
Research Overview
- Phase III Randomized Double‑Masked Sham‑Controlled Trial of Intravitreal IL6‑Mab in Patients with Uveitic Macular Edema
- Phase 3 Randomized, Double-Masked, Placebo-Controlled Trial of Brepocitinib Tosilate in Adults with Active Non-Infectious Intermediate, Posterior, and Panuveitis
- A Randomized, Controlled, Partially Masked, Phase 3b Study to Assess the Injection Burden, Efficacy, Safety, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec (ABBV-RGX-314) in a Real-World Context in Subjects with Neovascular Age-Related Macular Degeneration (nAMD)
Data & Insights
Has run more than one trial at 23 of 115 partner sites.
Specializations
Ophthalmologic Conditions
The investigator specializes in treating complex uveitic conditions, with particular emphasis on various forms of eye inflammation and related complications.
- Uveitic Macular Edema
- Non-infectious Uveitis
- Posterior Uveitis
- Panuveitis
The investigator focuses on advanced therapeutic approaches for managing inflammatory eye conditions affecting different segments of the uvea.
Visual Function Management
The investigator concentrates on improving functional vision outcomes in patients with inflammatory eye disorders, particularly focusing on best corrected visual acuity.
- Visual Function Assessment
- Intravitreal Therapeutics
- Vision Restoration Approaches
Their work encompasses comprehensive evaluation and treatment of vision-threatening inflammatory conditions.
Treatment Innovation
The investigator evaluates novel therapeutic approaches for managing inflammatory eye disorders, including advanced pharmaceutical interventions.
- Innovative Drug Development
- Anti-inflammatory Therapies
- Targeted Ocular Treatments
Their research explores new treatment modalities for inflammatory eye conditions resistant to conventional therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.